Default filter shows currently active projects. To see projects at other stages, use the status filters.
To enable CDC to scale up its activity of investing and lending to support the building of businesses in developing countries, to create jobs and make a lasting difference to people’s lives in some of the world's poorest places. CDC is DFID’s main vehicle for investing in private companies in Africa and South Asia. CDC encourages capital investments from other private investors by being a first mover, demonstrating to other investors that commercial returns are possible in these frontier markets, and by sharing risk and expertise. The additional equity from DFID will enable CDC to meet demand for capital in its target markets and allow CDC to sustain a higher volume of more developmental investments across priority regions and business sectors
UK contribution to the 18th Replenishment of the World Bank International Development Association (IDA 18)
The United Kingdom's Contribution to the European Development Fund (EDF) for Aid under the Cotonou Agreement. This project was approved before the referendum on the UK’s membership of the EU. Work is now under way to understand the implications of leaving the EU for the UK’s development work
To provide the Department for International Development's (DFID) contribution to the European Union's activities in support of economic development and poverty reduction in Asia and Latin American countries and South Africa. The European Union activities contribute towards Member States pledges to commit 0.7% of Gross National Income (GNI) on Official Development Assistance (ODA)
UK contributions to compensate IDA the costs of foregone debt service payments under the Multilateral Debt Relief Initiative (MDRI)
Reduce vaccine preventable diseases (VPDs) in poor countries in a sustainable way using innovative financing approach
To tackle the immediate impact of the three most deadly infectious diseases – HIV/AIDS, tuberculosis and malaria – and put the international community on the right track to end the three diseases as epidemics by 2030.
Gavi currently works in 73 countries to save children’s lives by increasing equitable use of vaccines in the world’s poorest countries (the number will reduce as countries graduate from Gavi support). Gavi immunises children against vaccine preventable diseases including measles, rubella, cervical cancer (via the human papilloma virus vaccine) and certain types of pneumonia and diarrhoea. Pneumonia and diarrhoea are two of the biggest causes of deaths among children in the developing world and cervical cancer is a leading cause of death for women in Africa. Gavi will also have an important role to play if effective vaccines are produced against malaria and ebola. During 2016-2020, Gavi will in particular target reaching those in hard to reach areas in its target countries. Gavi also works with manufacturers to reduce the cost of vaccines for countries. The UK investment through Gavi will immunise an additional 75 million children against diseases and save over 1.25 million lives.
To support development and poverty reduction through environmental protection, and help developing countries respond to climate change
To scale up access to treatment for HIV/Aids, Malaria and Tuberculosis for poor people by funding programmes that (often through bulk international procurement) lower the price of quality drugs and diagnostics and accelerating the pace at which they are made available.